Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Stevenage Bioscience Catalyst
Stevenage Bioscience Catalyst
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Bevel edge or radius edge flat face tablets: Which is better for greater consumer acceptance?
Consumers and patients should perceive that their tablets are easy to swallow and devoid of any undesirable taste. Tablet manufacturers can influence acceptance of by producing...
The (r)evolution of biocatalysis in API synthesis
Explore Farmhispania Group’s enzyme toolbox to develop cost-effective, green-by-design synthetic routes for the cGMP production of your small-molecule NCEs
Berry Global invests to increase production capacity for healthcare products
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
BIO International Convention Digital
3-6 June, 2024 | Convention | San Diego, US
See all
Related Content
Design & Build
GE Healthcare to open biotechnology manufacturing centre in UK
Located at the Stevenage Bioscience Catalyst, the facility includes 280sqm of cleanroom space
Research & Development
Consortium of UK Universities and global pharma companies launch £40m innovation fund
Apollo Therapeutics Fund will support translation of academic science into medicines for a broad range of diseases
Research & Development
Ian Tomlinson becomes Independent Chairman of Stevenage Bioscience Catalyst Board
Will guide open innovation campus in a phase of rapid development
Research & Development
Stevenage Bioscience Catalyst to fund six projects to fight neurodegenerative disease
Diverse players collaborate on first step in plan to tackle disorder through open innovation
Research & Development
New £55m cell therapy manufacturing centre to be built in Stevenage, UK
Will open in 2017 and create up to 150 jobs
Research & Development
GE Healthcare Life Sciences links up with Stevenage Bioscience Catalyst (SBC)
Joins neurodegenerative disease challenge and expands commitment to open innovation in healthcare
Research & Development
Stevenage Bioscience Catalyst gains £3m in funding
One tenant has also secured further funding, while another has extended its research collaborations
Subscribe now